Cite
Clinical efficacy and safety profile of allergen-specific immunotherapy using microcrystalline tyrosine (MCT)-adsorbed allergoids - A meta-analysis
MLA
Becker, S., et al. Clinical Efficacy and Safety Profile of Allergen-Specific Immunotherapy Using Microcrystalline Tyrosine (MCT)-Adsorbed Allergoids - A Meta-Analysis. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1238105384&authtype=sso&custid=ns315887.
APA
Becker, S., Zieglmayer, P., Canto, G., Fassio, F., Yong, P., Acikel, C., Raskopf, E., Steveling, E., Allekotte, S., & Moesges, R. (2020). Clinical efficacy and safety profile of allergen-specific immunotherapy using microcrystalline tyrosine (MCT)-adsorbed allergoids - A meta-analysis.
Chicago
Becker, S., P. Zieglmayer, G. Canto, F. Fassio, P. Yong, C. Acikel, E. Raskopf, E. Steveling, S. Allekotte, and R. Moesges. 2020. “Clinical Efficacy and Safety Profile of Allergen-Specific Immunotherapy Using Microcrystalline Tyrosine (MCT)-Adsorbed Allergoids - A Meta-Analysis.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1238105384&authtype=sso&custid=ns315887.